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ABSTRACT
Objective: Anemia in chronic kidney disease (CKD) contributes in decreasing quality life, but specific hemoglobin associated with quality of life is 
still in debate. Anemia was thought to be one of contributing factors of low physical activity in CKD, but this finding is inconsistent across studies. 
This research study aims to investigate the association of hemoglobin levels with quality of life and physical activity in hemodialysis patients in our 
settings.
Methods: This study was conducted between March 30, 2020, and April 30, 2020, in hemodialysis unit, Wangaya Regional General Hospital, Bali. The 
study included 50 subjects on regular hemodialysis. Subject-reported quality of life was evaluated by interview, based on Kidney Disease Quality of 
Life (KDQOL)-36TM questionnaire. Self-reported physical activity level was assessed by International Physical Activity Questionnaires (IPAQ).
Results: Quality of life in burden of kidney disease categories is different significantly between hemoglobin levels group (*p=0.034). There is 
significant difference between hemoglobin levels < 8 g/dL with 8.1–12 g/dL (**p=0.01) and hemoglobin levels < 8 g/dL with > 12 g/dL (*p=0.034). 
For self-reported physical activity, hemoglobin level was not associated with physical activity in Fisher’s exact test analysis (p=1.000).
Conclusion: We found that hemoglobin levels > 8 g/dL were associated with higher quality of life in hemodialysis patient. Hemoglobin levels were not 
associated with physical activity. Recommended hemoglobin levels to support the best quality of life and physical activity without increasing mortality 
rate are still in need to be further evaluated.
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INTRODUCTION
Chronic kidney disease (CKD) is still recognized as one of the major 
issues worldwide [1]. Besides the unfavorable disease outcome, CKD 
has also great economic burden which makes CKD a huge global 
problem [1,2]. In Indonesia, kidney disease ranks as the second most 
spender in the national health-care budget [3].
Since 2000, the prevalence of end-stage renal disease was 13,4% [4]. One 
in five men and one in four women between 65 and 74 years old suffered 
from CKD. According to data from Global Burden of Disease Study (GBD), 
in 2015, the mortality rate of CKD has increased by around 32% since 
2005 and reached 1.2 million globally [2,5]. Data also showed that there 
were 2 million death cases of CKD because of the limited access in renal 
replacement therapy [6]. CKD is often associated with reduced quality 
of life due to its complications [7]. Hemodialysis in CKD is performed 
to replace kidney function in end-stage renal disease. It is frequently 
associated with complications such as hemodynamic disorders, 
arrhythmia, cramping, nausea and vomiting, headache, and anemia [8].
Anemia, one of the most frequent complications of CKD, found 
increases in number as the disease progresses [9]. It was found in 
50% of cases in CKD and 75% of people who are undergoing regular 
hemodialysis [10]. Erythropoietin deficiency, decreased red blood cells 
life span, abnormal iron metabolism, and chronic inflammation were 
the known mechanisms of anemia in CKD [9,11]. Anemia in CKD was 
also associated with the disease progression, increased mortality rate, 
and unfavorable outcome [12]. A study from Hoshino et al. showed that 
increased hemoglobin levels alleviated some symptoms in CKD such as 
depressions and insomnia in non-hemodialysis patients [13].
Low physical activity was another common problem found in CKD. 
Physical inactivity also affected some functional aspects including quality 
of life in CKD [14], even it was strongly associated with mortality [15]. 
Anemia was thought to be one of the contributing factors of low 
physical activity [16,17] as well as low quality of life in CKD [18-20], but 
this finding was inconsistent across some studies [21-23]. In Indonesia, 
we use Kidney Disease Improving Global Outcomes (KDIGO) guidelines 
which also did not provide the specific hemoglobin to be achieved for 
better quality of life and physical activity [24]. Some of these studies 
result was not applicable in our settings. We also hardly found any 
studies assessing the quality of life and physical activity of hemodialysis 
patients, especially in our setting. Take into account these findings, we 
would like to investigate the correlation of hemoglobin levels with 
the quality of life and physical activity in hemodialysis patients in our 
settings.
This research study aims to investigate the association of hemoglobin 
levels with the quality of life and physical activity in hemodialysis 
patients in our settings.
METHODS
This study was conducted between March 30, 2020, and April 30, 2020, 
in hemodialysis unit, Wangaya Regional General Hospital, Denpasar, 
Bali. This study included 50 subjects with regular hemodialysis who 
met our criteria: (1) Age between 18 and 69 years old; (2) on regular 
hemodialysis twice a week for at least 3 months; and (3) had agreed 
to participate in our study. No subject undergoes peritoneal dialysis in 
this study.
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2020.v13i8.37983
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Subjects with a history of active bleeding and major surgery in 
the previous 3 months were excluded from the study. Exclusion 
criteria were also applied on subjects with wheelchair, physically or 
neurologically disabled, having mental and intellectual disorders, 
Alzheimer’s disease, other conditions which heavily affected subjects 
to answer the interview questions, decided to stop participating in this 
study in the middle of interview, and no laboratory data measurements 
during the past 3 months.
This research was approved by the Research Ethics Committee of 
Wangaya General Hospital, 023/III/KEP/RSW/2020, according to the 
standards for conducting research with human beings, provided in 
Council for International Organizations of Medical Sciences (CIOMS) 
2016 World Health Organization (WHO). The participants in this 
study were told about objective, risks and benefits, and asked to sign 
an informed consent form. A preannouncement of the study was 
performed by the staff nurse in charge before data collection. Data were 
taken directly by authors.
Of the 65 participants, one was excluded because not in our age settings, 
three subjects declined to participate. Sixty-one subjects consented to 
participate. Nine subjects were excluded (five subjects had a history of 
stroke and used wheelchair, one subject had a history of neurological 
disorder and wheel-chair dependent, one subject only communicated 
using local language, one subject suffered from mental disorder, and one 
subject had no recent laboratory test data and refused to do the blood 
test) and two subjects died during data collection process, resulting in 
50 subjects included in final data analysis (Fig. 1).
Hemoglobin level and other laboratory parameters used for the study 
were measurements in the past 3 months. Anemia in our settings was 
all treated by erythropoietin-α subcutaneously. Iron injection was given 
to all hemodialysis patients every first date visit in the month. Most of 
the patients were given folic acid. Anemia was classified into <8 g/dL, 
8.1–12 g/dL, and >12 g/dL.
Subject-reported quality of life was assessed using interview, based 
on Kidney Disease Quality of Life (KDQOL-36TM) questionnaire 
by research and development (RAND). The Indonesian version of 
KDQOL-36TM had already been tested for validity and reliability by 
Supriyadi et al. [25]. The questionnaire consists of 36 questions 
which measures five aspects: (1) Symptom/problem list; (2) effects of 
kidney disease; (3) burden of kidney disease; (4) physical composite; 
and (5) mental composite. Each measurement would have a score 
range of 0–100, with higher scores indicating better quality of life in 
each aspect.
Self-reported physical activity level was assessed by International 
Physical Activity Questionnaire (IPAQ) which had been translated 
into Indonesian language. Physical activity was categorized into low, 
moderate, and high activity based on the interpretation.
Data analysis was performed using Statistical Package for the Social 
Sciences (SPSS) 25 software. Correlation of hemoglobin level and 
quality of life was analyzed using Kruskal–Wallis, followed by Mann–
Whitney analysis to determine which groups had significant difference. 
For physical activity outcome, we used Fisher’s exact analysis. For 




In Wangaya General Regional Hospital, all of our subjects had 
hemodialysis twice a week for 4.5 h each session. Subjects had 
hemodialysis from the arteriovenous shunt. Thirty-two subjects 
(64%) are male, with most of them (24 subjects; 48%) finished high 
school. Forty-three subjects (50%) had hemoglobin levels 8.1–12 g/dL, 
3 (6%) of them had hemoglobin levels <8 g/dL, and 4 (8%) of them 
had hemoglobin levels >12 g/dL. Eight subjects (16%) had a history 
of hospitalization in the past 3 months. In terms of hemodialysis 
(HD) duration, most of the subjects (48 subjects) had HD <5 years, 
with most of them had hemoglobin levels 8.1–12 g/dL. Most frequent 
comorbidities in subject were hypertension (90%) followed by diabetes 
mellitus (30%). Only 8% of subjects had chronic hepatitis B and 2% of 
them had chronic hepatitis C infection (Table 1).
Quality of life
Subjects’ quality of life was categorized into symptom/problem list, 
effects of kidney disease, burden of kidney disease, SF-12 physical 
mental health composite, and SF-12 mental health composite. In 
KDQOL-36TM questionnaire, the higher the number, the better the 
quality of life. After analyzing the data, we found that quality of life in 
burden of kidney disease category was different significantly between 
hemoglobin levels group (*p=0.034) (Table 2). For the burden of kidney 
disease category, subjects with higher hemoglobin levels had a higher 
score (25±16.5 for hemoglobin levels <8 g/dL, 71.8±23.1 for hemoglobin 
levels 8.1–12 g/dL, and 73.4±10.7 for hemoglobin levels >12 g/dL). 
In post hoc analysis, we found that between hemoglobin levels group, 
there were significant differences between hemoglobin levels <8 g/dL 
with hemoglobin levels 8.1–12 g/dL (*p=0.01) and hemoglobin levels 
<8 g/dL with hemoglobin levels >12 g/dL (*p=0.034).
Age was associated with the burden of kidney disease categories 
(**p=0.000; r=0.483) and physical health composite categories 
(*p=0.016; r=−0.339). Hospitalization in the past 3 months was 
associated with quality of life in burden of kidney disease category 
(*p=0.038) and physical health composite category (**p=0.006). 
Hemodialysis duration was also associated with quality of life in burden 
of kidney disease category (*p=0.028), physical health composite 
category (*p=0.014), and mental health composite category (p=0.016). 
Other demographic factors were analyzed and not associated with 
quality of life. For comorbidities, hypertension was associated with 
physical health composite category (*p=0.013), glomerulonephritis 
was associated with symptom/problem list category (p=0.007), 
and urolithiasis was associated with the burden of kidney disease 
category (*p=0.032). Other demographic factors were analyzed but not 
associated significantly with quality of life.
Physical activity
Almost all of our subjects (98%) had low to moderate level of physical 
activity. For self-reported physical activity, 50%, 48%, and 2% were 
categorized as low, moderate, and high physical activity, respectively. 
Only one subject had a high level of physical activity with hemoglobin 
levels 8.1–12 g/dL. In our study, hemoglobin levels were not associated 
with physical activity using Fisher’s exact test (p=1.000) (Table 3). Other 
demographic factors also were not associated with physical activity.
Subjects underwent regular hemodialysis (n = 65)
Subjects declined to participate
(n = 3)
Subject was out of our age
range (n = 1)
Subjects consented to participate (n = 61)
Subjects were





Subjects included in final data analysis (n = 50)
Subjects had history
of stroke and used
wheelchair (n = 5)
Subject had history of
neurological disorder and
wheelchair-dependent (n = 1)
Subject only communicated
using local language (n = 1)
Subject suffered from
mental disorder (n = 1)
Subject had no recent
laboratory test data and refused
to do the blood test (n = 1)
Fig. 1: Flowchart of subjects recruitment and exclusion
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DISCUSSION
Quality of life
The KDQOL-36TM questionnaire is a valid and reliable tool for 
measuring quality of life in dialysis patients. It offers a deep 
interpretation of the variables related to the quality of life in HD 
patients [26]. Higher score in the questionnaire is interpreted as 
higher quality of life. Most of the subjects’ complaints were of fluid 
restriction. In women, they usually complained about the bulging 
appearance of the AV shunt.
Quality of life in burden of kidney disease categories was different 
significantly between hemoglobin levels group (*p=0.034). There 
was a significant difference between hemoglobin levels < 8 g/dL with 
hemoglobin levels 8.1–12 g/dL (**p=0.01) and hemoglobin levels 
< 8 g/dL with hemoglobin levels > 12 g/dL (*p=0.034). This suggested 
that hemoglobin levels > 8 g/dL were associated with better quality of life.
This finding differed from Hoshino et al. and Finkelstein et al. studies 
which found that hemoglobin levels >12 g/dL were associated with a 
higher quality of life comparing to lower hemoglobin levels [13,27]. This 
difference might be caused by different studies’ subjects. They used non-
dialysis subjects, whereas in this study, we used regular hemodialysis 
patients. In HD patients, high hemoglobin levels were found to have 
hemodynamic and symptomatic advantages, but it was often associated 
with higher mortality due to increased risk of hypertension and stroke. In 
terms of hemoglobin levels, recommended hemoglobin levels for dialysis 
Table 2: Quality of life by hemoglobin levels
Quality of life domain (Mean ± SD) Hemoglobin levels (g/dL) P-value
<8.0 8.1–12 >12
n=3 6% n=43 86% n=4 8%
Symptom/problem list 82.6±16.2 78.5±18.1 81.3±13.9 p=0.900
Effects of kidney disease 53.1±27 81.3±19.2 91.4±6.9 p=0.095
Burden of kidney disease 25±16.5 71.8±23.1 73.4±10.7 *p=0.034
SF-12 physical health composite 25.6±7.5 38.1±10.2 33.1±11.4 p=0.079
SF-12 mental health composite 52.6±8 49.7±12 46.8±20 p=0.125
SF: Short form
Table 3: Physical activity by hemoglobin levels
Physical activity Hemoglobin levels (g/dL)
<8.0 8.1–12 >12
n=3 6% n=43 86% n=4 8%
Low 2 4 21 42 2 4
Moderate 1 2 21 42 2 4
High 0 0 1 2 0 0
Table 1: Baseline patient characteristics by hemoglobin levels
Parameters Hemoglobin levels (g/dL)
<8.0 8.1–12 >12
n=3 6% n=43 86% n=4 8%
Demographic
Sex Male 3 6% 25 50% 4 8%
Female 0 0% 18 36% 0 0%
Age (years) 52±7 50±12 47±20
Education No formal education 0 0% 3 0% 0 0%
Primary school 0 0% 9 18% 0 0%
Junior high school 0 0% 1 2% 0 0%
High school 1 2% 20 40% 3 6%
Bachelor degree 2 4% 8 16% 1 2%
Master degree 0 0% 1 2% 0 0%
Doctoral degree 0 0% 1 2% 0 0%
Smoking history 2 4% 6 12% 0 0%
Hospitalization in the past 3 months 2 4% 6 12% 0 0%
HD duration <5 years 3 6% 42 84% 3 6%
> 5 years 0 0% 1 2% 1 2%
Laboratory parameters (Mean ± SD)
eGFR (ml/minute/1.73 m3) 4.09±0.93 4.8±2.2 4.53±1.14
Creatinine (µmol/L) 1134.72±260 993.35±316.13 1085.80±306.36
Comorbidities
Hypertension 3 6% 38 76% 4 8%
Diabetes mellitus 1 2% 13 26% 1 2%
Heart disease 0 0% 4 8% 0 0%
Glomerulonephritis 0 0% 5 10% 0 0%
Hyperuricemia 0 0% 2 4% 0 0%
SLE 0 0% 0 0% 1 2%
Hepatitis B 0 0% 4 8% 0 0%
Hepatitis C 1 2% 0 0% 0 0%
Chronic diarrhea 0 0% 1 2% 0 0%
Urolithiasis 2 4% 2 4% 0 0%
Nephrotic syndrome 0 0% 1 2% 0 0%
HD: Hemodialysis, eGFR: Estimated glomerular filtration rate, SLE: Systemic lupus erythematosus
72
Asian J Pharm Clin Res, Vol 13, Issue 8, 2020, 69-73
 Daniella et al.
patients are 11 g/dL, but the hemoglobin levels associated with an adverse 
event remain elusive [28]. In this study, we found that hemoglobin levels 
> 8 g/dL was associated with better quality of life. This was probably 
due to most subjects who was unemployed and had low physical activity. 
Therefore, low hemoglobin levels did not affect their activities and 
quality of life. Another cause was due to their mental well-being, such as 
acceptance of their end-stage kidney disease. In Asian countries, especially 
in Indonesia, most general population had relatively high kinship with 
children and parents which they still lived together, further increasing the 
quality of life due to better family support. Grievance was usually reported 
in the first few months after CKD diagnosis and the need for hemodialysis 
were determined, but in our setting, hemodialysis was performed 
altogether with other patients, this might shorten the grieving period. All 
of the subjects have already passed the grieving period. Therefore, they 
tended to have better quality of life. This statement is supported by Cruz 
et al. which shows that low quality of life score was shown in an early stage 
of CKD, especially in the first two stages [22].
Other demographic factors that associated with quality of life are age, 
history of hospitalization in the past 3 months, hemodialysis duration, 
and comorbidities. Age and hospitalization are associated with the 
burden of kidney disease and physical health composite categories. The 
same result was found in a recent study in which age was associated 
with worse physical health and > 60 years old was associated with 
worse quality of life [29]. Hemodialysis duration was also associated 
with quality of life in burden of kidney disease, physical health 
composite, and mental health composite categories. This finding was 
consistent with Seica et al. [30].
In comorbidities related factors, hypertension, glomerulonephritis, 
and urolithiasis are associated with quality of life. These comorbidities 
were associated with low quality of life and low score on SF-12 physical 
and mental health composite [22].
Most of the studies stated that education was associated with quality 
of life, Most of previous studies found that higher education level was 
associated with better quality of life [22,26,30]. However, in our studies, 
we found that education was not associated with quality of life. This 
is probably due to most of the patients who are high school graduates 
with enough capacity to understand their disease or has been given 
adequate information to fully comprehend their disease, or has passed 
the grieving period.
Physical activity
The IPAQ short form is a simple and quick self-reported questionnaire 
to assess subjects’ physical activity. A study comparing IPAQ and 
accelerometer had moderate correlations among patients undergoing 
hemodialysis [31]. Another study comparing IPAQ and pedometer 
in CKD patients also found a modest correlation between both 
measurements [32]. Therefore, IPAQ is still preferred in this study 
in addition to the preferred age range included comparing to other 
questionnaires.
From the data analysis, the hemoglobin level was not correlated with 
physical activity level (p=1.000). This finding differs from the previous 
studies [13,33]. Hoshino et al. also found declining physical activity 
level decreased proportionally with lower Hb levels between 10.5 g/
dL and 13 g/dL [13]. Our study used the IPAQ questionnaire which 
depends on the memory of the subjects regarding the activity level. This 
may cause subjective findings in reporting the subjects’ activity level. 
Results in the previous study also found that IPAQ may underestimate 
light physical activity [31]. This also may contribute to the difference 
in our results.
Creatinine level was previously reported being associated with 
individual muscle mass regardless of protein intake. High creatinine 
level was associated with increasing score of physical health 
composite [34]. However, in our study, creatinine was correlated with 
neither health-related quality of life nor physical activity. Studies had 
also found a relationship between declining glomerular filtration rate 
and physical function. We also did not find any relationship between 
these variables. No relationship was also found among our variables 
with level of activity.
There were a number of barriers affecting physical activity, such as 
using AV shunt in the dominant hand would hinder the subjects to 
do certain exercises and activity. Some patients also feared for feeling 
shortness of breath if they tried to exercise higher physical activity. 
These also affected our results.
There are a few limitations to our cross-sectional study. The routine 
erythropoietin injection makes the lesser variability of hemoglobin 
levels. The small sample size in our study might also make limited 
conclusions to extreme value of hemoglobin. Our study also did not 
include a control group. Other physical activity measurements such as 
pedometer and accelerometer were not used in our study due to limited 
funding in our study. In addition, accelerometer tends to underestimate 
the absolute amount of daily activity performed [35] and low-intensity 
walking. Pedometer may not be able to measure additional activities 
beyond walking [32]. We did not measure some other confounding 
factors such as nutritional status and serum calcium, phosphate, and 
albumin which could affect the result of our study.
CONCLUSION
We found that hemoglobin levels >8 g/dL was associated with the 
burden of kidney disease categories of quality of life in hemodialysis 
patients. In our study, hemoglobin level was not associated with 
physical activity. Recommended hemoglobin levels to support the best 
quality of life and physical activity without increasing mortality rate 
were still needed to be evaluated.
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